Biological AI’s real moat is data, not the model, says Ekei Labs founder
markjeffrey · x · 2026-07-23
The main point of the quoted TWiST discussion is that for biological AI companies, the moat is data, not the model.
- Bilal Kharouni of Ekei Labs argues that the real advantage comes from collecting biological data that competitors do not have.
- The episode also discusses why $200K in Japan can outperform $2M in San Francisco, why Ekei shut down a profitable side business to stay focused, and a broader reassessment of so-called longevity “Blue Zones.”
- The clip is framed as a startup strategy conversation rather than a model or product announcement.
More from AGI Musings
- In the LLM era of STEM, the low-hanging fruit is still worth taking — littmath · 2026-07-23
- Model evals miss the point when they ignore tail reliability — eugeneyan · 2026-07-23
- If AI did the intellectual work, authorship should probably go to the model — littmath · 2026-07-23
- LLMs may soon make secure financial systems impossible, author says — birchlse · 2026-07-23
- Anyone may soon run a superhuman coding agent at home, and cybersecurity may fail — birchlse · 2026-07-23
- A researcher warns that a runaway agent could bring down the cloud and internet — shakoistsLog · 2026-07-23